- Home
-
Product Finder
- Arixtra®▼ (Fondaparinux sodium)
- Arzerra®▼ (ofatumumab)
- Atriance® (nelarabine)
- Avamys®▼ (Fluticasone Furoate)
- Avodart® (dutasteride)
- Benlysta®▼ (belimumab)
- Combodart™▼ (0.5 mg dutasteride / 0.4 mg tamsulosin hydrochloride)
- Duodart™▼ (0.5 mg dutasteride / 0.4 mg tamsulosin hydrochloride)
- Hycamtin®▼ (topotecan)
- ReQuip®LP (ropinirole hydrochloride prolonged-release tablets)
- ReQuip® PD (ropinirole hydrochloride prolonged-release tablets)
- ReQuip®XL (ropinirole hydrochloride prolonged-release tablets)
- ReQuip Depot® (ropinirole hydrochloride prolonged-release tablets)
- ReQuip Modutab™ (ropinirole hydrochloride prolonged-release tablets)
- ReQuip Prolib™ and ReQuip® prolonged-release tablets (ropinirole hydrochloride prolonged-release tablets)
- Revolade®▼ (eltrombopag)
- Seretide® (salmeterol xinafoate/fluticasone propionate)
- Trobalt™▼ (Retigabine)
- Tyverb®▼ (lapatinib)
- Viani® (salmeterol xinafoate/fluticasone propionate)
- Votrient®▼ (pazopanib)
- belimumab (Benlysta®▼)
- dutasteride (Avodart®)
- eltrombopag (Revolade®▼)
- Fondaparinux sodium (Arixtra®▼)
- Fluticasone Furoate (Avamys®▼)
- lapatinib (Tyverb®▼)
- nelarabine (Atriance®)
- ofatumumab (Arzerra®▼)
- pazopanib (Votrient™▼)
- ropinirole hydrochloride prolonged-release tablets (ReQuip Modutab™, also known as ReQuip®LP, ReQuip® PD, ReQuip®XL, ReQuip Depot®, ReQuip Prolib™ and ReQuip® prolonged-release tablets)
- Retigabine (Trobalt™▼)
- salmeterol xinafoate/fluticasone propionate (Seretide®, also known as Viani®)
- topotecan (Hycamtin®▼)
- Therapy Areas
- News
- Media and Resources
-
20 Jul 2010
GSK pandemic influenza website has moved
The GSK website for pandemic influenza has moved from health.gsk.com to pandemic.gsk.com.
-
19 Jul 2010
health.gsk is the European GSK website providing on licence online product-related information for both healthcare professionals and members of the public